The global biologics market is projected to reach USD 567.96 Billion in 2028 at a steady revenue CAGR of 8.4% over the forecast period, according to latest analysis by Emergen Research. Some key factors attributed to steady market revenue growth include rising demand for monoclonal antibodies, recombinant hormones/proteins, gene-based & cellular-based biologics, vaccines, and molecular therapy, etc. in the treatment of diseases including cancer, infectious diseases, immunological diseases, cardiovascular diseases, and hematological diseases, among others. Also, rising use of biologics for the treatment of autoimmune diseases, comprising various arthritis types, including ankylosing spondylitis, rheumatoid arthritis, and psoriatic arthritis, is playing a crucial role in driving revenue growth of the global biologics market. Biologics function by creating an inflammation disruption, thereby resulting in a reduction in joint pain.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
Novo Nordisk A/S, Pfizer Inc., Amgen, Sanofi, Samsung BioLogics, Merck & Co. Inc., Celltrion, AbbVie Inc., Johnson & Johnson Services Inc., Eli Lilly & Company, F Hoffman La Roche, Addgene, Novartis AG, and GlaxoSmithKline.
Download Sample Report @ https://www.emergenresearch.com/request-sample/61
Biologics Market Trends :
Monoclonal antibodies are the biologic drugs that have so far gotten the most widespread approval. However, novel biologic drugs including nanobodies, synthetic vaccines, fusion proteins, antisense RNAi therapeutics, and gene and cell therapy are currently the subject of clinical trials. It is projected that the availability of multiple such drugs in the clinical development pipeline and their approval will drive market expansion.
Some Key Highlights From The Report
In September 2020, Biocon Biologics Ltd. and Mylan made an announcement about the introduction of biosimilar Semglee in the US. This biosimilar is available, both in pre-filled pen and vials, and is intended for controlling high blood pressure in adults having type 2 diabetes and pediatric patients having type 1 diabetes.
Ask For Discount @ https://www.emergenresearch.com/request-discount/61
ย Market Drivers:
The constant efforts of prominent players to develop newer and modern technologies and product advancements are expected to drive the growth of the industry over the coming years. The report studies the extensive business expansion plans and advancements in R&D activities and product portfolio. The report offers a clear understanding of the alliances in the market, such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches and brand promotions, and corporate deals.
Among the source segments, mammalian segment revenue is expected to register a significantly rapid growth rate over forecast period. Expression systems deploying mammalian cells for recombinant hormones/proteins can introduce appropriate protein folding, PTM (post-translational modifications), and product assembly that are essential for overall biological activity.
The vaccines segment revenue is anticipated to grow at a considerably faster rate throughout the projection period among the product type segments. A vaccine works by assisting the immune system in recognising and combating bacteria or viruses that are pathogens. Due to the effectiveness of vaccinations in lowering communicable diseases that may be prevented, fewer people are currently affected by the distressing symptoms of diseases like measles and pertussis, among others. To stop the spread of COVID-19 and the subsequent deaths brought on by the disease, vaccination demand is currently skyrocketing around the globe.
Access Sample Copy @ https://www.emergenresearch.com/request-sample/61
Major Inclusions-
Qualitative as well as quantitative assessment of the market on the basis of the detailed categorization involving both the economic and non-economic factors.
Analysis at country and regional level, which portrays the share of the product or service in different regions.
Elaborative company profiles section, which provides different pointers such as key executives, business enactment, company overview, product/service portfolio, R&D expenditure, current scenario, and prime strategies of the key market players.
The forecasted market outlook of the Biologics Market based on recent developments, which incorporate the analysis of drivers, market trends, and growth opportunities.
The COVID-19 impact on the Biologics Market
Post-sales support and free customization
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ , Speak To Our Expert @ https://www.emergenresearch.com/call-schedule/61
Emergen Research has segmented the global biologics on the basis of source, product type, application, and region:
biologics Market Source Outlook (Revenue, USD Billion; 2018-2028)
Microbial
Mammalian
Others
biologics Market Product Type Outlook (Revenue, USD Billion; 2018-2028)
Monoclonal Antibodies
Vaccines
Recombinant Hormones/Proteins
Cellular-Based Biologics
Gene-Based Biologics
Others
biologics Market Application Outlook (Revenue, USD Billion; 2018-2028)
Cancer
Infectious Diseases
Immunological Diseases
Cardiovascular Diseases
Hematological Disorders
Others
Buy Now @ https://www.emergenresearch.com/select-license/61
Regional Analysis Covers:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Our Top Reports :
About Emergen Research :
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.With market-leading insights and an in-depth understanding of leading and niche technologies, our solutions address the most pertinent questions for your business needs. A major technological shift has been witnessed towards creating a โCircular Economy,โ fuelled by factors, such as the increased adoption of bio-based materials, along with other methods for achieving carbon neutrality. We are conversant in technologies, viz., Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), Robotic Process Automation (RPA), Smart Manufacturing, Internet of Things (IoT), Big Data Analytics, Machine learning, Nanotechnology, Edge Computing, Blockchain Technology, Cloud Computing, Vehicle Electrification, Advanced Maintenance Analytics, and Predictive Maintenance, among other prevalent and emergent technologies.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Latest Reports: Botulinum Toxin Market | Dermocosmetics Market
Trending Titles: cannabis market | in-vehicle infotainment market
Thank you for reading our report. For further details or to inquire about customization, please let us know. We will offer you the report as per your needs.